Financhill
Back

OncoCyte Quote, Financials, Valuation and Earnings

OncoCyte Price Quote

$2.23
+0.02 (+0.91%)
(Updated: December 21, 2024 at 5:40 AM ET)

OncoCyte Key Stats

Sell
21
OncoCyte (OCX) is a Sell

Day range:
$2.15 - $2.27
52-week range:
$1.98 - $3.82
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
33.60
P/B ratio:
3.83%

Volume:
78.2K
Avg. volume:
117.6K
1-year change:
-21.35%
Market cap:
$37.2M
Revenue:
$1.5M
EPS:
$-4.54

How Much Does OncoCyte Make?

Data Unavailable

Is OncoCyte Growing As A Company?

Data Unavailable

OncoCyte Stock Price Performance

  • Did OncoCyte Stock Go Up Last Month?
    OncoCyte share price went down by -19.64% last month
  • Did OCX's Share Price Rise Over The Last Year?
    OCX share price fell by -21.35% over the past 1 year

What Is OncoCyte 52-Week High & Low?

  • What Is OncoCyte’s 52-Week High Share Price?
    OncoCyte has traded as high as $3.82 over the past 52 weeks
  • What Is OncoCyte’s 52-Week Low Share Price?
    OncoCyte has traded as low as $1.98 over the past 52 weeks

OncoCyte Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy OncoCyte?

Data Unavailable

Is OncoCyte Cash Flow Positive?

Data Unavailable

OncoCyte Return On Invested Capital

Data Unavailable

OncoCyte Earnings Date & Stock Price

  • What Is OncoCyte's Stock Price Today?
    A single share of OCX can be purchased today for 2.21
  • What Is OncoCyte’s Stock Symbol?
    OncoCyte trades on the nasdaq under the ticker symbol: OCX
  • When Is OncoCyte’s Next Earnings Date?
    The next quarterly earnings date for OncoCyte is scheduled on April 11, 2025
  • When Is OCX's next ex-dividend date?
    OncoCyte's next ex-dividend date is December 22, 2024
  • How To Buy OncoCyte Stock?
    You can buy OncoCyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

OncoCyte Competitors

  • Who Are OncoCyte's Competitors?
    Below is a list of companies who compete with OncoCyte or are related in some way:
    • Applied DNA Sciences Inc (APDN)
    • Fonar Corp (FONR)
    • ProPhase Labs Inc (PRPH)
    • Veracyte Inc (VCYT)
    • XWELL Inc (XWEL)

OncoCyte Dividend Yield

Data Unavailable

OncoCyte Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -16.76%
Revenue: -73.19% -31.68%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable